Trial Profile
A Preliminary Study to Evaluate the Effects of Palifermin in Patients at Risk of Chronic Graft-versus-host Disease.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Palifermin (Primary)
- Indications Graft-versus-host disease
- Focus Biomarker; Therapeutic Use
- 06 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 06 Sep 2011 Planned end date changed from 1 Dec 2010 to 1 Jul 2012 as reported by ClinicalTrials.gov.